Raytel Medical has signed a letter of intent to acquire Cardiovascular Ventures of New Orleans, an operator of cardiovascular diagnostic facilities in Texas, Louisiana, and Maryland. The proposed agreement fits Raytel's new business strategy of expanding
Raytel Medical has signed a letter of intent to acquire Cardiovascular Ventures of New Orleans, an operator of cardiovascular diagnostic facilities in Texas, Louisiana, and Maryland. The proposed agreement fits Raytel's new business strategy of expanding in the cardiovascular center market by building a network of integrated heart centers. Cardiovascular Ventures had revenues of about $17.3 million and was profitable for the first nine months of the fiscal year (end-June). Raytel in May said it was evaluating its options in its other business, the operation of medical imaging centers, which it may divest to concentrate on its heart center network (SCAN 5/14/97).
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.